In our study (N = 1024), we also found the superior predictive performance of serum LDH/ALB, and serum LDH/ALB was not only a strong prognostic biomarker for unfavorable OS but also an independent risk element for inferior DFS in CRC patients. Here, ALB is linked to colorectal carcinoma.